📊 AI Agent for Data Science. Alibaba Backs SiliconFlow. Deep Learning Meets Drug Discovery.

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/03/68/2a/03682a8b-e152-760e-0070-b3ea3e5f1026/mza_2941613334855061170.jpg/600x600bb.jpg

China AI Briefing (formerly China AI Daily)

China AI Briefing

25 episodes

3 days ago

This is China AI Briefing (formerly China AI Daily), your shortcut to understanding China’s booming AI and tech scene and its global ripple effect. Each week, we bring you digestible updates on what matters most, so you stay in the loop without feeling overwhelmed. For daily briefings and bonus deep dives, visit chinaaibriefing.substack.com

Tech News

News

RSS

All content for China AI Briefing (formerly China AI Daily) is the property of China AI Briefing and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Tech News

News

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/44012281/9ad148cb89543c3f.jpg

📊 AI Agent for Data Science. Alibaba Backs SiliconFlow. Deep Learning Meets Drug Discovery.

China AI Briefing (formerly China AI Daily)

2 minutes 43 seconds

4 months ago

📊 AI Agent for Data Science. Alibaba Backs SiliconFlow. Deep Learning Meets Drug Discovery.

🎙️ In today’s episode:

SenseTime x Ant Group: SenseTime’s “Little Raccoon” AI assistant joins forces with Ant Toolbox to offer smart, multimodal data analysis, coming soon to Alipay.
SiliconFlow’s Big Raise: The AI infra startup lands major funding from Alibaba Cloud, expanding its one-stop model hosting platform SiliconCloud.
DeepDTAGen: Researchers unveil a new multitask AI model that predicts drug-target affinity and generates target-specific compounds, potentially transforming pharmaceutical R&D.

🔗 Links & Resources:

DeepDTAGen: https://www.nature.com/articles/s41467-025-59917-6

⚠️ Disclaimer: This episode was scripted and narrated using AI tools. All software is licensed for commercial use, and content complies with platform guidelines.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit chinaaibriefing.substack.com